Clinical Study

Oxidant Status and Lipid Composition of Erythrocyte Membranes in Patients with Type 2 Diabetes, Chronic Liver Damage, and a Combination of Both Pathologies

Table 1

TBARS, nitrites, and cysteine levels from serum and red blood cells obtained from control subjects and from patients with type 2 DM and/or cirrhosis.

ParameterHealthy ( )Diabetes ( )Cirrhosis ( )Diab + Cirrhos ( )

Serum TBARS0.35 ± 0.130.40 ± 0.100.37 ± 0.090.42 ± 0.18
RBC TBARS0.42 ± 110.62 ± 0.08*1.15 ± 0.35*0.84 ± 0.35*,***
RBC/serum ratio1.20 ± 0.341.55 ± 0.29*3.11 ± 0.89*2.00 ± 0.78*

Serum nitrites26 ± 337 ± 863 ± 25*46 ± 18*
RBC nitrites32 ± 668 ± 7*150 ± 47*62 ± 24*
RBC/serum ratio1.2 ± 0.21.8 ± 0.3*2.3 ± 0.9*1.4 ± 0.4

Serum cysteine18 ± 444 ± 12*28 ± 9*39 ± 15*
RBC cysteine23 ± 737 ± 10153 ± 52*87 ± 34*,***
RBC/serum ratio1.3 ± 0.30.8 ± 0.25.3 ± 1.8*2.2 ± 0.9*,***

Results are expressed as mean ± SD of determinations done in blood samples membranes from controls ( ), patients with type 2 DM ( ), cirrhotic patients ( ), and diabetic patients with cirrhosis ( ). RBC: red blood cells. Statistical significance: * , versus control; ** , versus DM or versus cirrhosis; *** , versus both the diabetes and cirrhosis groups, separately.